Description: The Cystic Fibrosis (CF) Foundation developed clinical care guidelines for the
prevention of Pseudomonas aeruginosa infection, the treatment of initial P. aeruginosa …

Pseudomonas aeruginosa (PA) is a pathogen that is recognized for its advanced antibiotic
resistance and its association with serious diseases such as ventilator-associated …

Pseudomonas aeruginosa opportunistically infects the airways of patients with cystic fibrosis
and causes significant morbidity and mortality. Initial infection can often be eradicated …

There seems to be a growing curiosity for utilizing MIPs to recognize molecules that can be
applied in numerous fields, such as biomimetic antibodies, detection of viruses and bacteria …

In 1882, Robert Koch suggested four postulates that establish causation between an
infectious agent and a particular disease:(1) the infectious organism must be found in …

Abstract Background An Expert Forum was held at the 2014 European Respiratory Society
International Congress to address issues involved in the management of Pseudomonas …

Cystic fibrosis (CF) lung disease is characterised by recurring bacterial infections resulting in
inflammation, lung damage and ultimately respiratory failure. Pseudomonas aeruginosa is …

Pseudomonas aeruginosa is a gram-negative non–lactose fermenting oxidase-positive
bacterium that causes infection in patients with compromised immune systems and/or …

Nachdem die letzten Jahrzehnte durch eine zunehmende Ausbreitung grampositiver
nosokomialer Infektionserreger gekennzeichnet waren, zeichnet sich in den letzten Jahren …

Pseudomonas aeruginosa is an opportunistic pathogen causing acute and chronic
respiratory infections associated with morbidity and mortality, especially in patients with …